Panacea Biotec Ltd.

NSE: PANACEABIO | BSE: 531349 | ISIN: INE922B01023 | Industry: Biotechnology
| Momentum Trap
430.4000 -6.95 (-1.59%)
NSE Jun 18, 2025 14:42 PM
Volume: 134.9K
 

430.40
-1.59%
Rudra Shares and Stock Brokers Ltd
Robust product pipeline of promising niche products to fuel long term future growth, Strong Product Portfolio with significant brand market share in respective therapeutic segment, PANACEA is amongst the top 50 innovators in India with strong foundation of over two decades. Eyeing on Recent updates & highlights Amongst 6 WHO pre-qualified Suppliers of pentavalent vaccine US ANDAs - 3 approved; 3 pending for approval; 23 under development...
Number of FII/FPI investors increased from 11 to 22 in Mar 2025 qtr.
More from Panacea Biotec Ltd.
Recommended